
### [MONDO:0015215](http://purl.obolibrary.org/obo/MONDO_0015215)
**Label:** non-syndromic diaphragmatic or abdominal wall malformation

**Subclasses:** [MONDO:0010606](http://purl.obolibrary.org/obo/MONDO_0010606) (hernia, anterior diaphragmatic), [MONDO:0005711](http://purl.obolibrary.org/obo/MONDO_0005711) (congenital diaphragmatic hernia), [MONDO:0009264](http://purl.obolibrary.org/obo/MONDO_0009264) (gastroschisis), [MONDO:0019765](http://purl.obolibrary.org/obo/MONDO_0019765) (Celosomia), [MONDO:0012431](http://purl.obolibrary.org/obo/MONDO_0012431) (diaphragmatic hernia 3), [MONDO:0019015](http://purl.obolibrary.org/obo/MONDO_0019015) (omphalocele (disease)), [MONDO:0009103](http://purl.obolibrary.org/obo/MONDO_0009103) (DIH2), [MONDO:0008124](http://purl.obolibrary.org/obo/MONDO_0008124) (omphalocele, autosomal), [MONDO:0007719](http://purl.obolibrary.org/obo/MONDO_0007719) (diaphragmatic hernia, congenital 1), [MONDO:0010696](http://purl.obolibrary.org/obo/MONDO_0010696) (omphalocele, X-linked), [MONDO:0018847](http://purl.obolibrary.org/obo/MONDO_0018847) (Omphalomesenteric cyst), 

**Mapped go classes:** [GO:0060045](http://purl.obolibrary.org/obo/GO_0060045) (positive regulation of cardiac muscle cell proliferation), [GO:2000020](http://purl.obolibrary.org/obo/GO_2000020) (positive regulation of male gonad development), [GO:0003192](http://purl.obolibrary.org/obo/GO_0003192) (mitral valve formation), [GO:0003195](http://purl.obolibrary.org/obo/GO_0003195) (tricuspid valve formation), [GO:0003151](http://purl.obolibrary.org/obo/GO_0003151) (outflow tract morphogenesis), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0003148](http://purl.obolibrary.org/obo/GO_0003148) (outflow tract septum morphogenesis), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0055008](http://purl.obolibrary.org/obo/GO_0055008) (cardiac muscle tissue morphogenesis), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0003181](http://purl.obolibrary.org/obo/GO_0003181) (atrioventricular valve morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:2000195](http://purl.obolibrary.org/obo/GO_2000195) (negative regulation of female gonad development), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0060979](http://purl.obolibrary.org/obo/GO_0060979) (vasculogenesis involved in coronary vascular morphogenesis), [GO:0003221](http://purl.obolibrary.org/obo/GO_0003221) (right ventricular cardiac muscle tissue morphogenesis), [GO:0060412](http://purl.obolibrary.org/obo/GO_0060412) (ventricular septum morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), 

**Class expressions from DL-Learner:**

- [GO:0003190](http://purl.obolibrary.org/obo/GO_0003190) (atrioventricular valve formation) 61.11%
- [GO:0003195](http://purl.obolibrary.org/obo/GO_0003195) (tricuspid valve formation) 55.56%
- [GO:0003192](http://purl.obolibrary.org/obo/GO_0003192) (mitral valve formation) 55.56%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005097](http://purl.obolibrary.org/obo/GO_0005097) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005084](http://purl.obolibrary.org/obo/GO_0005084) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005083](http://purl.obolibrary.org/obo/GO_0005083) (null) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005082](http://purl.obolibrary.org/obo/GO_0005082) (obsolete receptor signaling protein tyrosine phosphatase signaling protein activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005081](http://purl.obolibrary.org/obo/GO_0005081) (obsolete receptor signaling protein serine/threonine phosphatase signaling protein activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005079](http://purl.obolibrary.org/obo/GO_0005079) (obsolete protein kinase A anchoring activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005077](http://purl.obolibrary.org/obo/GO_0005077) (obsolete MAP-kinase anchoring activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005076](http://purl.obolibrary.org/obo/GO_0005076) (obsolete receptor signaling protein serine/threonine kinase signaling protein activity) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005075](http://purl.obolibrary.org/obo/GO_0005075) (obsolete pathway-specific SMAD protein) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005074](http://purl.obolibrary.org/obo/GO_0005074) (obsolete inhibitory SMAD protein) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%
- [GO:0003188](http://purl.obolibrary.org/obo/GO_0003188) (heart valve formation) and ([GO:0005073](http://purl.obolibrary.org/obo/GO_0005073) (obsolete common-partner SMAD protein) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 51.94%


